Parkinson’s Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up diciembre 27, 1919diciembre 27, 2022
Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up. diciembre 27, 1919diciembre 27, 2022
Identifying comorbidities and lifestyle factors that contribute to cognitive impairment in early Parkinson’s disease depends on cognitive screening tools used diciembre 27, 1919diciembre 27, 2022
Predictors of Clinically Significant Quality of Life Impairment in Parkinson´s Disease. Results from the COPPADIS Cohort at 2-Year Follow-up diciembre 27, 1919diciembre 27, 2022
Predictors of Loss of Functional Independence in Parkinson´s Disease. Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group diciembre 27, 1919diciembre 27, 2022
Constipation Predicts Cognitive Decline in Parkinson´s Disease. Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group diciembre 27, 1919diciembre 27, 2022
Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson´s Disease. Results from the COPPADIS Cohort at 2-Year Follow-up. diciembre 21, 1919diciembre 21, 2022
In-vivo cholinergic basal forebrain degeneration and cognition in Parkinson’s disease: imaging results from the COPPADIS study. diciembre 21, 1919diciembre 21, 2022
Staging Parkinson´s Disease Combining Motor and Non-motor Symptoms Correlates with Disability and Quality of Life. diciembre 21, 1919diciembre 21, 2022
